Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA approves Novoste's 60mm radiation source:

This article was originally published in Clinica

Executive Summary

The US FDA has given Novoste the green light to market its Beta-Cath system with a longer 60mm radiation source, which is suitable for the treatment of long, diffuse in-stent restenosis. Patients with diffuse, in-stent restenosis typically have the worst clinical outcomes due to the complexity of their disease, says the Atlanta, Georgia firm. The Beta-Cath product line already includes 30-mm and 40mm radiation source lengths.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts